Based on their association with allergy and the protein fold change (more than 1.1 or less than 0.9) between ATI responders and non-responders, four potential genes (MUC5B, LBP, C4BPB, LTA4H) were identified as potential biomarkers that indicate an effective AIT. This evidence concerns the gene MUC5B and allergic disease.